Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-006990
Filing Date
2021-03-26
Accepted
2021-03-26 09:30:14
Documents
1
Period of Report
2021-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2659
  Complete submission text file 0001567619-21-006990.txt   4324
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEOS THERAPEUTICS, INC. 2940 N. HIGHWAY 360 GRAND PRAIRIE TX 75050
Business Address
Hecht Beth (Reporting) CIK: 0001652410 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38247 | Film No.: 21775063